LeMaitre Vascular, Inc. (NASDAQ:LMAT) is set to announce third quarter earning results on Thursday 29th October 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, LMAT to report 3Q20 income of $ 0.19 per share.
For the full year, analysts anticipate top line of $ 120.47 million, while looking forward to income of $ 0.74 per share bottom line.
The Company Outlook
Earnings for 3Q20 are anticipated in a range of $ 0.17 ~ $ 0.26 per share, while revenues are expected in a range of $ 30.50 million ~ $ 34.50 million
Full Year 2020 topline are forecasted in a range of$ 127.40 million ~ $ 130.80 million, where as bottomline are predicted in a range of $ 0.90 ~ $ 0.98 per share
Click Here For More Historical Outlooks Of LeMaitre Vascular, Inc.
Previous Quarter Performance
LeMaitre Vascular, Inc. unfold income for the second quarter of $ 0.17 per share, from the revenue of $ 24.85 million. The quarterly earnings decreased 26.09 percent while revenues declined 15.71 percent compared with the same quarter last year. The top line results outshined analysts by $ 7.73 million or 45.15 percent.
Stock Performance
Shares of LeMaitre Vascular, Inc. traded low $ -0.16 or -0.48 percent on Wednesday, reaching $ 33.05 with volume of 137.80 thousand shares. LeMaitre Vascular, Inc. has traded high as $ 33.25 and has cracked $ 32.30 on the downward trend
According to the previous trading day, closing price of $ 33.05, representing a 77.03 % increase from the 52 week low of $ 18.76 and a 14.05 % decrease over the 52 week high of $ 38.64.
The company has a market capital of $ 668.51 million and is part of the Healthcare sector and Medical Instruments & Supplies industry.
Conference Call
LeMaitre Vascular, Inc. will be hosting a conference call at 5:00 PM eastern time on 29th October 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.lemaitre.com
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company offers angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to temporarily perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system.
